Inhibition of VEGFR2 does not affect the overexpression of KLF2 or KLF4 after CCM2 loss [42], but it can partially prevent the development of cavernomas in CCM1-deficient animals [24]. The gene discussed is KLF2; the disease is cavernous hemangioma.